DJ Inovio Pharmaceuticals Inc. Stock Remains Steady Wednesday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ were unchanged Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.60% to 18,276.65 and Dow Jones Industrial Average falling 0.96% to 42,514.95.
Inovio Pharmaceuticals Inc. closed $9.05 below its 52-week high ($14.75), which the company reached on April 1st.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.47% to $165.86.
Trading volume (243,537) remained 62,152 below its 50-day average volume of 305,689.
Data source: Dow Jones Market Data, FactSet. Data compiled October 23, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 23, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。